ArticleBioengineering & translational medicine2017

Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis.

Shiven Kapur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.